Diffuse large B-cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

被引：7

作者：

Wight, Joel ^{[1
,2
,3
,4
]}

Hamad, Nada ^{[12
,13
,14
]}

Campbell, Belinda A. ^{[5
,7
,9
]}

Ku, Matthew ^{[8
]}

Lee, Kenneth ^{[15
,16
]}

Rose, Hannah ^{[10
,11
]}

Armytage, Tasman ^{[18
]}

Latimer, Maya ^{[19
,20
]}

Lee, Hui-Peng ^{[21
]}

Lee, Sze-Ting ^{[3
]}

Dickinson, Michael ^{[4
,6
,9
]}

Khor, Richard ^{[3
]}

Verner, Emma ^{[15
,17
]}

机构：

[1] James Cook Univ, Dept Haematol & Bone Marrow Transplantat, Townsville Univ Hosp, Townsville, Qld, Australia

[2] James Cook Univ, Sch Med, Townsville, Qld, Australia

[3] Univ Melbourne, Dept Haematol, Austin Hlth, Melbourne, Vic, Australia

[4] Univ Melbourne, Sch Med, Melbourne, Vic, Australia

[5] Univ Melbourne, Sch Med, Dept Radiat Oncol, Melbourne, Vic, Australia

[6] Univ Melbourne, Peter MacCallum Canc Ctr, Haematol, Melbourne, Vic, Australia

[7] Univ Melbourne, Dept Clin Pathol, Melbourne, Vic, Australia

[8] St Vincents Hosp, Dept Haematol, Melbourne, Vic, Australia

[9] Univ Melbourne, Dept Oncol, Parkville, Vic, Australia

[10] Deakin Univ, Dept Haematol, Univ Hosp, Geelong, Vic, Australia

[11] Deakin Univ, Sch Med, Geelong, Vic, Australia

[12] Univ Notre Dame, Dept Haematol, St Vincents Hosp, Notre Dame, IN USA

[13] Univ Notre Dame, Sch Med, Notre Dame, IN 46556 USA

[14] Univ New South Wales, St Vincents Clin Sch, Kensington, NSW, Australia

[15] Univ Sydney, Sch Med, Sydney, NSW, Australia

[16] Concord Repatriat Gen Hosp, NSW Hlth Pathol, Anat Pathol Dept, Sydney, NSW, Australia

[17] Concord Repatriat Gen Hosp, Dept Haematol, Sydney, NSW, Australia

[18] Gosford Hosp, Dept Haematol, Gosford, NSW, Australia

[19] Australian Natl Univ, Canberra Hosp, Dept Haematol, Canberra, ACT, Australia

[20] Australian Natl Univ, Dept Haematol, Canberra, ACT, Australia

[21] Flinders Med Ctr, Dept Haematol, Adelaide, SA, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2022年 / 52卷 / 09期

关键词：

diffuse large B-cell lymphoma; diagnosis; prognosis; management; POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKIN-LYMPHOMA; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; INTERNATIONAL PROGNOSTIC INDEX; AGGRESSIVE NON-HODGKIN; HIGH-DOSE CHEMOTHERAPY; HIGH-RISK PATIENTS; BONE-MARROW-TRANSPLANTATION; SOUTHWEST-ONCOLOGY-GROUP; CHOP-LIKE CHEMOTHERAPY;

D O I：

10.1111/imj.15533

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype, accounting for 30-40% of lymphoma diagnoses. Although aggressive, cure is achievable in approximately 60% of cases with primary chemoimmunotherapy, and in a further substantial minority by salvage therapy and autologous stem cell transplantation. Despite promising activity in early phase clinical trials, no intensified or novel treatment regimen has improved outcomes over R-CHOP21 in randomised studies. However, there remain several areas of controversy including the most appropriate prognostic markers, central nervous system prophylaxis and the optimal treatment for patients with high-risk disease. This position statement presents an evidence-based synthesis of the literature for application in Australasian practice.

引用

页码：1609 / 1623

页数：15

共 50 条

[21] Diffuse large B-cell lymphoma
Alcantara, Marion
Huynh, Tony
HEMATOLOGIE, 2016, 22 (02): : 159 - 166
[22] Unclassifiable B-cell lymphoma: Between diffuse large B-cell lymphoma and Burkitt lymphoma
Mandi, Y.
Malihy, A.
Kettani, F.
Alaammari, I.
Khmou, M.
Touri, S.
Rouas, L.
Lamalmi, N.
El Khorassani, M.
Alhamany, Z.
ARCHIVES DE PEDIATRIE, 2015, 22 (06): : 661 - 664
[23] Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance
Hapgood, Greg
Latimer, Maya
Lee, Sze Ting
Kuss, Bryone
Lade, Stephen
Tobin, Joshua W. D.
Purtill, Duncan
Campbell, Belinda A.
Prince, H. Miles
Hawkes, Eliza A.
Shortt, Jake
Radeski, Dejan
INTERNAL MEDICINE JOURNAL, 2022, 52 (10) : 1806 - 1817
[24] B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma
Ci, Weimin
Polo, Jose M.
Melnick, Ari
CURRENT OPINION IN HEMATOLOGY, 2008, 15 (04) : 381 - 390
[25] Transformation of diffuse large B-cell lymphoma to lymphoblastic lymphoma
Kushwaha, Pritika
Singh, Meeta
Mallya, Varuna
Jain, Shyama
Aggarwal, Sunita
Singh, Kishore
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (09) : S475 - S477
[26] Burkitt lymphoma versus diffuse large B-cell lymphoma
Rosenwald, A.
Ott, G.
ANNALS OF ONCOLOGY, 2008, 19 : 67 - 69
[27] Cutaneous diffuse large B-cell lymphoma, leg type, secondary to testicular diffuse large B-cell lymphoma
Pampin, A.
Gomez-de la Fuente, E.
Feltes, R. A.
Pinedo, F.
Rodriguez-Peralto, J. L.
Lopez-Estebaranz, J. L.
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (02) : 230 - 232
[28] Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance
Boyle, Stephen
Tobin, Joshua W. D.
Perram, Jacinta
Hamad, Nada
Gullapalli, Veena
Barraclough, Allison
Singaraveloo, Lydia
Han, Min-Hi
Blennerhassett, Richard
Nelson, Niles
Johnston, Anna M.
Talaulikar, Dipti
Karpe, Krishna
Bhattacharyya, Abir
Cheah, Chan Yoon
Subramoniapillai, Elango
Bokhari, Waqas
Lee, Cindy
Hawkes, Eliza A.
Jabbour, Andrew
Strasser, Simone, I
Chadban, Steven J.
Brown, Christina
Mollee, Peter
Hapgood, Greg
HEMASPHERE, 2021, 5 (11): : E648
[29] The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice
Mendeville, Matias
Roemer, Margaretha G. M.
Los-de Vries, G. Tjitske
Chamuleau, Martine E. D.
de Jong, Daphne
Ylstra, Bauke
FRONTIERS IN ONCOLOGY, 2022, 12
[30] Tisagenlecleucel in Diffuse Large B-Cell Lymphoma
Schwartz, Jonathan D.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (16): : 1585 - 1586

← 1 2 3 4 5 →